A Win For SELLAS Life Sciences Group, Inc.

Wed 09 Dec 20 at 05:30 PM

SELLAS Life Sciences Group, Inc. (SLS:NASDAQ) jumped higher at $6.39, representing a gain of 73.2%. The stock got featured on our News Catalysts scanner on Mon 07 Dec 20 at 10:48 AM in the 'AGREEMENT' category. From Tue 24 Nov 20, the stock recorded 66.67% Up Days and 70.00% Green Days

The stock spiked on Fri 31 Jul 20 at $4.43 with a volume of 2M+, and its share price has been moving sideways in recent weeks.

About SELLAS Life Sciences Group, Inc. (SLS:NASDAQ)

Galena Biopharma Inc is a biopharmaceutical company. It is focused on developing and commercializing targeted oncology therapeutics that addresses unmet medical needs.

Top 10 Gainers:

GLSI (GLSI:NASDAQ), 998.08%
Xenetic Biosciences, Inc. (XBIO:NASDAQ), 193.52%
Arlington Asset Investment Corp. (AI:NYSE), 120.21%
SV (SV:NASDAQ), 100%
DoorDash Inc (DASH:NASDAQ), 85.79%
Rocket Pharmaceuticals, Inc. (RCKT:NASDAQ), 83.39%
SELLAS Life Sciences Group, Inc. (SLS:NASDAQ), 73.17%
MTS Systems Corporation (MTSC:NASDAQ), 51.84%
ChinaNet Online Holdings, Inc. (CNET:NASDAQ), 39.04%
Tuscan Holdings Corp. (THCB:NASDAQ), 34.59%